Literature DB >> 23804381

Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea.

Vijay C Antharam1, Eric C Li, Arif Ishmael, Anuj Sharma, Volker Mai, Kenneth H Rand, Gary P Wang.   

Abstract

Clostridium difficile infection (CDI) causes nearly half a million cases of diarrhea and colitis in the United States each year. Although the importance of the gut microbiota in C. difficile pathogenesis is well recognized, components of the human gut flora critical for colonization resistance are not known. Culture-independent high-density Roche 454 pyrosequencing was used to survey the distal gut microbiota for 39 individuals with CDI, 36 subjects with C. difficile-negative nosocomial diarrhea (CDN), and 40 healthy control subjects. A total of 526,071 partial 16S rRNA sequence reads of the V1 to V3 regions were aligned with 16S databases, identifying 3,531 bacterial phylotypes from 115 fecal samples. Genomic analysis revealed significant alterations of organism lineages in both the CDI and CDN groups, which were accompanied by marked decreases in microbial diversity and species richness driven primarily by a paucity of phylotypes within the Firmicutes phylum. Normally abundant gut commensal organisms, including the Ruminococcaceae and Lachnospiraceae families and butyrate-producing C2 to C4 anaerobic fermenters, were significantly depleted in the CDI and CDN groups. These data demonstrate associations between the depletion of Ruminococcaceae, Lachnospiraceae, and butyrogenic bacteria in the gut microbiota and nosocomial diarrhea, including C. difficile infection. Mechanistic studies focusing on the functional roles of these organisms in diarrheal diseases and resistance against C. difficile colonization are warranted.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23804381      PMCID: PMC3754663          DOI: 10.1128/JCM.00845-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  43 in total

1.  Fecal bacteriotherapy or probiotics for the treatment of intestinal diseases?

Authors:  G Famularo; V Trinchieri; C De Simone
Journal:  Am J Gastroenterol       Date:  2001-07       Impact factor: 10.864

2.  Matrix2png: a utility for visualizing matrix data.

Authors:  Paul Pavlidis; William Stafford Noble
Journal:  Bioinformatics       Date:  2003-01-22       Impact factor: 6.937

3.  Taxonomy of the Clostridia: ribosomal ribonucleic acid homologies among the species.

Authors:  J L Johnson; B S Francis
Journal:  J Gen Microbiol       Date:  1975-06

4.  Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles.

Authors:  M J Hopkins; R Sharp; G T Macfarlane
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

5.  Role of volatile fatty acids in colonization resistance to Clostridium difficile in gnotobiotic mice.

Authors:  W J Su; M J Waechter; P Bourlioux; M Dolegeal; J Fourniat; G Mahuzier
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

6.  Role of volatile fatty acids in colonization resistance to Clostridium difficile.

Authors:  R D Rolfe
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

7.  Bacterial interference between Clostridium difficile and normal fecal flora.

Authors:  R D Rolfe; S Helebian; S M Finegold
Journal:  J Infect Dis       Date:  1981-03       Impact factor: 5.226

8.  Inhibition of Clostridium difficile strains by intestinal Lactobacillus species.

Authors:  Paul Naaber; Imbi Smidt; Jelena Štšepetova; Tatjana Brilene; Heidi Annuk; Marika Mikelsaar
Journal:  J Med Microbiol       Date:  2004-06       Impact factor: 2.472

9.  The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations.

Authors:  M D Collins; P A Lawson; A Willems; J J Cordoba; J Fernandez-Garayzabal; P Garcia; J Cai; H Hippe; J A Farrow
Journal:  Int J Syst Bacteriol       Date:  1994-10

10.  An in-vitro model of colonisation resistance to Clostridium difficile infection.

Authors:  S P Borriello; F E Barclay
Journal:  J Med Microbiol       Date:  1986-06       Impact factor: 2.472

View more
  201 in total

Review 1.  Considering the Immune System during Fecal Microbiota Transplantation for Clostridioides difficile Infection.

Authors:  Alyse L Frisbee; William A Petri
Journal:  Trends Mol Med       Date:  2020-02-17       Impact factor: 11.951

Review 2.  The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications.

Authors:  Jason R Goldsmith; R Balfour Sartor
Journal:  J Gastroenterol       Date:  2014-03-21       Impact factor: 7.527

3.  Intestinal Microbiota Is Altered in Patients with Gastric Cancer from Shanxi Province, China.

Authors:  Yu-Feng Qi; Jun-Ning Sun; Lai-Feng Ren; Xue-Ling Cao; Jian-Hong Dong; Kai Tao; Xue-Mei Guan; Ya-Ni Cui; Wen Su
Journal:  Dig Dis Sci       Date:  2018-12-07       Impact factor: 3.199

4.  Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection.

Authors:  Anna M Seekatz; Casey M Theriot; Krishna Rao; Yu-Ming Chang; Alison E Freeman; John Y Kao; Vincent B Young
Journal:  Anaerobe       Date:  2018-04-12       Impact factor: 3.331

Review 5.  Taming the Beast: Interplay between Gut Small Molecules and Enteric Pathogens.

Authors:  Aman Kumar; Melissa Ellermann; Vanessa Sperandio
Journal:  Infect Immun       Date:  2019-08-21       Impact factor: 3.441

Review 6.  Perspectives in lung microbiome research.

Authors:  Imran Sulaiman; Sheeja Schuster; Leopoldo N Segal
Journal:  Curr Opin Microbiol       Date:  2020-07-02       Impact factor: 7.934

7.  Nonantimicrobial drug targets for Clostridium difficile infections.

Authors:  Charles Darkoh; Magdalena Deaton; Herbert L DuPont
Journal:  Future Microbiol       Date:  2017-07-31       Impact factor: 3.165

8.  Protective Factors in the Intestinal Microbiome Against Clostridium difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Yeon Joo Lee; Esther S Arguello; Robert R Jenq; Eric Littmann; Grace J Kim; Liza C Miller; Lilan Ling; Cesar Figueroa; Elizabeth Robilotti; Miguel-Angel Perales; Juliet N Barker; Sergio Giralt; Marcel R M van den Brink; Eric G Pamer; Ying Taur
Journal:  J Infect Dis       Date:  2017-04-01       Impact factor: 5.226

9.  Relationship between clostridium difficile infection and gastrointestinal graft versus host disease in recipients of allogeneic stem cell transplantation.

Authors:  Divaya Bhutani; Charles Jaiyeoba; Seongho Kim; Paul Naylor; Joseph P Uberti; Voravit Ratanatharathorn; Lois Ayash; Abhinav Deol; Asif Alavi; Sanjay Revankar; Pranatharthi Chandrasekar
Journal:  Bone Marrow Transplant       Date:  2018-07-23       Impact factor: 5.483

Review 10.  Understanding Clostridium difficile Colonization.

Authors:  Monique J T Crobach; Jonathan J Vernon; Vivian G Loo; Ling Yuan Kong; Séverine Péchiné; Mark H Wilcox; Ed J Kuijper
Journal:  Clin Microbiol Rev       Date:  2018-03-14       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.